Document Mentions (4 shared documents)

EFTA00148445

2 mentions1 same-page

Page ?Same page

rketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug is approved for use in "people at least 12 years old and weighing at least 88 pounds (40 kilograms) who are hospitalized for a coronaviru

itors scheduled. This Town: • Brookings online discussion on the defense industrial base - 'The defense industrial base and the future of warfare' Brookings Institution Foreign Policy program online event exploring the future of the defense industrial base and challenges facing policymakers and the industry. Speake

EFTA02686105

2 mentions1 same-page

Page ?Same page

Kong SAR United Kingdom USA Israel USA USA United Kingdom United Kingdom Switzerland Switzerland South Africa United Kingdom DuPont USA National Institutes of Health USA YCAB (Yayasan Cinta Anak Indonesia Bangsa) Foundation Forrester Research Inc. USA Compagnie Financiere Switzerland Tradition Vodafone G

Limited Australia Director Ileana Grabitz Senior Economic Correspondent Die Welt Germany Carol Graham Charles Robinson Chair in Foreign The Brookings Institution USA Policy Studies Anne Graham Lotz Founder AnGeL Ministries USA Michael D. Granoff Chief Executive Officer Pomona Capital USA Hugh Grant

EFTA02686169

2 mentions1 same-page

Page ?Same page

negie Mellon University Vodafone Group Plc Riders for Health Swiss Television RTS Bank Julius Baer & Co. Ltd Absa Capital University of Oxford National Institutes of Health DuPont YCAB (Yayasan Cinta Anak Bangsa) Foundation People's Republic of China United Kingdom Republic of Korea Republic of Korea Republic of

Mutual Connections (2,240)

Entities connected to both National Institutes of Health and Brookings Institution

Donald Trump